The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark

BACKGROUND: Inhibitors of mutant BRAF are emerging as standard of care in patients with metastatic melanoma who carry relevant oncogenic mutations. However, BRAF inhibitors are found to induce cutaneous squamous cell carcinoma (cuSCC). Population-based background rates of cuSCC and non-cutaneous squ...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Haojie, Pedersen, Lars, Nørgaard, Mette, Ulrichsen, Sinna P., Thygesen, Sandra K., Nelson, Jeanenne J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855796/
https://www.ncbi.nlm.nih.gov/pubmed/27141983
http://dx.doi.org/10.1186/s12885-016-2315-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855796/
https://www.ncbi.nlm.nih.gov/pubmed/27141983
http://dx.doi.org/10.1186/s12885-016-2315-0

Ejemplares similares